MedPath

Neuromodulation to Facilitate the Effect of Ketamine

Completed
Conditions
Depression
Chronic Pain
Substance Abuse
Interventions
Other: co-administration of TMS and infused ketamine
Registration Number
NCT01816958
Lead Sponsor
The Neuroscience Center, LLC
Brief Summary

application of external neuromodulation along with ketamine infusion.

Detailed Description

apply TMS concurrent with ketamine infusion in order to increase the likliehood \& strength of therapeutic benefit

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • chronically ill,
  • treatment-resistant
Exclusion Criteria
  • active psychosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
chronic depression and/or painco-administration of TMS and infused ketamineco-administration of TMS and infused ketamine for patients with chronic pain of psyche and/or soma
Primary Outcome Measures
NameTimeMethod
Global Assessment of Function in DSM-4Rup to 3 years

treat in order to cause remission of disability

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Neuroscience Center

🇺🇸

Deerfield, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath